The first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) - Ceravac, a quadrivalent vaccine meaning it is effective against at least four variants of cancer-causing Human Papilloma Virus will be made available to the public in a few months.

Dr Nikhil Mehta Consultant Surgical Oncology, HCG Cancer Centre Jaipur shares his insights regarding the incidence of Cervical Cancer in India and the impact the new vaccine will make.

#CervicCancer #togethertowin #HCG

свернуть